Pharmaceutical company Pneuma Respiratory Inc revealed on Friday the addition of shareholder J. Knox Singleton to its board of directors.
Singleton has served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, until his retirement in July 2018.
Previously, Singleton received numerous awards during his career in recognition of his leadership in the field of health care.
According to the company, Singleton is a Phi Beta Kappa graduate of the University of North Carolina, where he earned a Bachelor of Science Degree in Business Administration and he holds a Master's Degree in Health Administration from Duke University.
Insilico Medicine doses first patient in Phase III trial of rentosertib
Altesa BioSciences presents positive vapendavir clinical data at ERS International Congress 2026
Akeso's ivonescimab meets overall survival endpoint in interim analysis of Phase III HARMONi-2 study
Kazia Therapeutics reports 100% clinical benefit rate in initial paxalisib breast cancer trial
Oxcia receives EMA orphan designation for OXC-201 in idiopathic pulmonary fibrosis
Cizzle Bio presents CIZ1B biomarker blood test for lung cancer at Next Generation Dx Summit
Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance
Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease
Azra AI and 4DMedical partner on lung health intelligence
AstraZeneca reports positive Phase III results for Tagrisso and Orpathys
HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination
ArkBio's Ziresovir gains US FDA Phase II clinical trial approval